The average one-year price target for MetaVia (NasdaqCM:MTVA) has been revised to $68.08 / share. This is a decrease of 15.51% from the prior estimate of $80.58 dated March 25, 2026. The price target ...
MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Phase 1 Part 3 Trial of DA-1726 to Initiate in April 2026 On March 18 ...
MetaVia, Inc. (NASDAQ:MTVA) is currently conducting a Phase 1 clinical trial of DA-1726, the company’s oxyntomodulin (OXM) analog that is a dual agonist of the glucagon-like peptide-1 receptor (GLP1R) ...
View MetaVia Inc. MTVA stock quote prices, financial information, real-time forecasts, and company news from CNN.
The Metropolitan Television Alliance (MTVA) has named a new president. Edward Grebow will leave his position as deputy president of Sony to head MTVA. The MTVA is a coalition of New York City area ...
The average one-year price target for MetaVia (NasdaqCM:MTVA) has been revised to $159.88 / share. This is an increase of 1,000.00% from the prior estimate of $14.54 dated November 14, 2025. The price ...
Short interest in MetaVia Inc (NASDAQ:MTVA) decreased during the last reporting period, falling from 198.09K to 60.60K. This put 6.38% of the company's publicly available shares short. Based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results